Related Experiment Video
Updated: May 16, 2025

An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
SOX9 suppresses colon cancer via inhibiting epithelial-mesenchymal transition and SOX2 induction
Ying Feng1, Ningxin Zhu1, Karan Bedi2
1Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, United States of America.
Abstract:
The Wnt/β-catenin pathway regulates expression of the SOX9 gene, which encodes sex-determining region Y-box (SOX) transcription factor 9, a differentiation factor and potential β-catenin regulator. Because APC tumor suppressor defects in approximately 80% of colorectal cancers (CRCs) activate the Wnt/β-catenin pathway, we studied SOX9 inactivation in CRC biology. Compared with effects of Apc inactivation in mouse colon tumors, combined Apc and Sox9 inactivation instigated more invasive tumors with epithelial-mesenchymal transition (EMT) and SOX2 stem cell factor upregulation. In an independent mouse CRC model with combined Apc, Kras, and Trp53 defects, Sox9 inactivation promoted SOX2 induction and distant metastases. About 20% of 171 human CRCs showed loss of SOX9 protein expression, which correlated with higher tumor grade. In an independent group of 376 patients with CRC, low SOX9 gene expression was linked to poor survival, earlier age at diagnosis, and increased lymph node involvement. SOX9 expression reductions in human CRC were linked to promoter methylation. EMT pathway gene expression changes were prominent in human CRCs with low SOX9 expression and in a mouse cancer model with high SOX2 expression. Our results indicate SOX9 has tumor suppressor function in CRC; its loss may promote progression, invasion, and poor prognosis by enhancing EMT and stem cell phenotypes.
Insights
Loss of SOX9 gene expression promotes colorectal cancer (CRC) progression and invasion. Reduced SOX9 is linked to poor prognosis, increased metastasis, and epithelial-mesenchymal transition (EMT) in CRC patients.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The Wnt/β-catenin pathway is crucial in cell regulation and is frequently dysregulated in colorectal cancer (CRC) due to APC mutations.
- SOX9, a transcription factor regulated by Wnt/β-catenin, plays a role in cell differentiation and may influence tumor progression.
Purpose of the Study:
- To investigate the role of SOX9 inactivation in colorectal cancer (CRC) biology.
- To determine the impact of SOX9 loss on tumor invasiveness, metastasis, and patient prognosis.
Main Methods:
- Utilized mouse models of colorectal cancer (CRC) with combined genetic defects (Apc, Sox9, Kras, Trp53).
- Analyzed SOX9 protein and gene expression in human CRC patient cohorts (n=171 and n=376).
- Assessed correlations between SOX9 expression, tumor grade, survival, lymph node involvement, and promoter methylation.
Main Results:
- Combined Apc and Sox9 inactivation in mice led to more invasive tumors with epithelial-mesenchymal transition (EMT) and SOX2 upregulation.
- Sox9 inactivation in another mouse CRC model promoted SOX2 induction and distant metastases.
- Loss of SOX9 protein was observed in ~20% of human CRCs, correlating with higher tumor grade.
- Low SOX9 gene expression in patients was linked to poor survival, earlier diagnosis, and increased lymph node metastasis.
- SOX9 expression reduction in human CRCs was associated with promoter methylation and prominent EMT pathway gene expression changes.
Conclusions:
- SOX9 exhibits tumor suppressor functions in colorectal cancer (CRC).
- Loss of SOX9 can promote CRC progression, invasion, and poor prognosis.
- SOX9 downregulation may enhance EMT and stem cell phenotypes, contributing to CRC advancement.
Related Concept Videos
Pleiotropy
Abnormal Proliferation
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Epigenetic Regulation
X-chromosome...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

